Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Pancréas » Néoplasie

14. Mai 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 3002


	Articles 1 - 20 / 60029

	Cancer loyalty card study-2 (CLOCS-2): protocol for an observational case-control study focusing on the patient interval in cancer diagnosis. BMJ Open Toopchiani S, Codling S, Pondeca Y, Kaur S, Horeau K, Brewer H, Cross A, Delaney B, Faisal AA, Peters C, Goulding J, Hirst Y, Sundar S, Flanagan JM. PMID: 42128509 [PubMed - indexed for MEDLINE]
	Randomised, multicentre phase II study of bevacizumab and paclitaxel induction followed by atezolizumab and nab-paclitaxel in patients with PD-L1-positive metastatic triple-negative breast cancer: protocol for the INDUCE trial (JBCRG-M10). BMJ Open Ozaki Y, Koyama S, Morita S, Miyashita M, Tokuda E, Shimoi T, Fukuoka M, Masuda H, Takano Y, Shibata N, Yoshinami T, Murakami A, Tamaki K, Ishiguro H, Saji S, Miwa A, Matsunaga J, Zheng Y, Nishikawa H, Masuda N. PMID: 42128502 [PubMed - indexed for MEDLINE]
	Beyond Performance Status: Optimize Cancer Care in Older Adults. Am Soc Clin Oncol Educ Book Lichtman SM. PMID: 42127340 [PubMed - indexed for MEDLINE]
	Tumor Mutational Concordance and Recurrence Timing in Hepatocellular Carcinoma. Hepatol Res Miura Y, Ashida R, Ohshima K, Okamura Y, Nagashima T, Hatakeyama K, Sugiura T, Ohgi K, Otsuka S, Dei H, Kakuda Y, Oishi T, Urakami K, Akiyama Y, Uesaka K, Yamaguchi K. PMID: 42127225 [PubMed - as supplied by publisher]
	Artificial intelligence in pancreatic cancer: applications in early detection, tumor staging, and survival prediction-a comprehensive review. Clin Transl Oncol Sethi N, Varma CV, Reddy SS. PMID: 42126789 [PubMed - as supplied by publisher]
	Clinical Presentation and Management Outcomes of Pancreatic Cancer in African Countries: A Scoping Review. J Gastrointest Cancer Gismalla MDA, Elhassan MMA, Abd Elrahman AAEA, Mohamedahmed AY, Saadeldien MSM, Aagla KYKA, Ahmed AMA, Abdelrahim WE, Balakrishnan A. PMID: 42126786 [PubMed - indexed for MEDLINE]
	Association between breast cancer, pancreatic cancer, and melanoma in a CDKN2A variant common in the Hispanic population. Fam Cancer Parkhurst ES, Natoli JL, Wei X, Luna DA, Maarup TJ. PMID: 42126713 [PubMed - indexed for MEDLINE]
	The association between periodontal disease and pancreatic cancer: epidemiology, mechanisms, and implications for clinical management. Front Cell Infect Microbiol Wang B, Cao H, Huang G, Song Y, Ma Y, Gao Z, Li S, Tang Z, Zhang H, Wei W. PMID: 42125497 [PubMed - indexed for MEDLINE]
	Hypoxic Tumor Microenvironment Targeting: Opportunities and Challenges for Pancreatic Cancer Immunotherapy. Int J Mol Sci Abou Khouzam R, Salman S, Thiery J, Zaarour RF, Vela V, Limani P, Janji B, Chouaib S. PMID: 42123455 [PubMed - indexed for MEDLINE]
	Pancreatic Cancer in the Holobiont and Therapeutic Targets: A Review. J Clin Med Terry C, Hall LA, Halle-Smith J, Edwards LA, Sivakumar S, Chapple I, Beggs A, Iqbal T, Roberts KJ. PMID: 42122957 [PubMed]
	Associations Between Routinely Measured Biomarkers and Pancreatic Cancer Risk in Individuals with Type 2 Diabetes Pre- and Post-Diagnosis. Cancers (Basel) Zhang Z, Carlsson S, Hammar N, Acedo P, Russell B, Kordasti S, Sarker D, Hemelrijck MV, Santaolalla A. PMID: 42122224 [PubMed]
	Therapeutic Cancer Vaccines in Gastrointestinal Malignancies: Advances, Challenges, and Emerging Strategies. Cancers (Basel) Taing K, Dabirian K, Shreenivas A. PMID: 42122214 [PubMed]
	Upfront Chemotherapy Versus Immediate Surgery for Operable Pancreatic Cancer: An Umbrella Review of Meta-Analyses. Cancers (Basel) Ghidini M, Ietto G, Dottorini L, Celotti A, De Giorgi A, Balzano G, Senzani F, Tomasello G, Petrelli F. PMID: 42122141 [PubMed]
	Uric Acid-Driven Biomarkers and Clinical Outcomes in Metastatic Pancreatic Cancer: A Multicenter Real-World Cohort Study. Diagnostics (Basel) Unlu A, Aydin AA, Baser MN, Turan M, Kocer M, Ozturk B, Yildiz M. PMID: 42122000 [PubMed]
	Combining Tumor Treating Fields with Immunotherapy in Pancreatic Ductal Adenocarcinoma: Mechanisms, Preclinical Evidence, and Emerging Therapeutic Synergy. Cells Albelal D, Rachamala HK, Saha I, Bhattacharya S, Mukhopadhyay D, Babiker HM. PMID: 42121946 [PubMed - indexed for MEDLINE]
	A Deep Dive into the Molecular and Immune Landscape of Undifferentiated Carcinomas with Osteoclast-like Giant Cells. Cells Chang E, Shi J. PMID: 42121938 [PubMed - indexed for MEDLINE]
	Programmable Poly-Lactic-Co-Glycolic Acid Nanocarriers for Precision Therapy of Pancreatic Ductal Adenocarcinoma. Drug Dev Res Gupta S, Nasir N, Wahab S, Gupta G, Goh KW, Kesharwani P. PMID: 42121392 [PubMed - indexed for MEDLINE]
	Biological Borderline Resectable Pancreatic Cancer Represents a Genetically and Immunologically Aggressive Subtype: A Retrospective Study. Ann Surg Arai Y, Masuda A, Tsujimae M, Tobimatsu K, Nanno Y, Sofue K, Sakai A, Kobayashi T, Gonda M, Inomata N, Miki M, Harada Y, Juri N, Irie Y, Ko T, Yokotani Y, Shirohata A, Kanamaru K, Tokunaga T, Yamamoto K, Okamoto K, Ogawa K, Kawase Y, Kageyama T, Kodama T, Imai T, Fukumoto T, Uza N, Kodama Y. PMID: 42121272 [PubMed - as supplied by publisher]
	Computed tomography-based sarcopenia and pancreatic cancer: Prognostic value and variability based on different methods and thresholds. Radiologia (Engl Ed) Gámez Martínez A, Valverde López F, Moreno Martínez MJ, López Cornejo D, Luengo Gómez D, Benítez JM, Láinez Ramos-Bossini AJ. PMID: 42120146 [PubMed - indexed for MEDLINE]
	Therapeutic potential of natural triterpenoids in pancreatic cancer. Semin Oncol Niu C, Han Y, Zhang J, Okolo PI 3rd. PMID: 42119258 [PubMed - as supplied by publisher]

Articles 1 - 20 / 60029

Page 1 de 3002



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité